Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Thom

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Rheumatology and Therapy|April 2, 2018
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect ComparisonPeter Nash, Iain B McInnes, Philip J Mease, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Research Synthesis Methods|February 2, 2026
Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makersA E Ades, Annabel L Davies, David M Phillippo, et al.
Rheumatology and Therapy|June 3, 2018
Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect ComparisonPeter Nash, Iain B McInnes, Philip J Mease, et al.
Dermatology and Therapy|December 8, 2021
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic DermatitisHoward Thom, Vincent Cheng, Edna Keeney, et al.
Journal of Comparative Effectiveness Research|February 27, 2019
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritisVibeke Strand, Iain McInnes, Philip Mease, et al.
Pharmacoeconomics - Open|November 29, 2019
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCTWilliam Hollingworth, Christopher G Fawsitt, Padraig Dixon, et al.
Health Technology Assessment (Winchester, England)|July 2, 2016
The feasibility of a randomised controlled trial of physiotherapy for adults with joint hypermobility syndromeShea Palmer, Fiona Cramp, Emma Clark, et al.
European Journal of Rheumatology|November 3, 2018
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparisonWalter P Maksymowych, Vibeke Strand, Peter Nash, et al.
European Journal of Neurology|June 10, 2026
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework ProposalCatalina Lopez Manzano, Claire M Rice, Emma Tallantyre, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Rheumatology and Therapy|April 2, 2018
Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect ComparisonPeter Nash, Iain B McInnes, Philip J Mease, et al.
Dermatology and Therapy|May 22, 2020
Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-AnalysisKyle Fahrbach, Jialu Tarpey, Evelien Bergrath Washington, et al.
Research Synthesis Methods|February 2, 2026
Treatment recommendations based on network meta-analysis: Rules for risk-averse decision-makersA E Ades, Annabel L Davies, David M Phillippo, et al.
Rheumatology and Therapy|June 3, 2018
Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect ComparisonPeter Nash, Iain B McInnes, Philip J Mease, et al.
Dermatology and Therapy|December 8, 2021
Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic DermatitisHoward Thom, Vincent Cheng, Edna Keeney, et al.
Journal of Comparative Effectiveness Research|February 27, 2019
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritisVibeke Strand, Iain McInnes, Philip Mease, et al.
Pharmacoeconomics - Open|November 29, 2019
Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCTWilliam Hollingworth, Christopher G Fawsitt, Padraig Dixon, et al.
Health Technology Assessment (Winchester, England)|July 2, 2016
The feasibility of a randomised controlled trial of physiotherapy for adults with joint hypermobility syndromeShea Palmer, Fiona Cramp, Emma Clark, et al.
European Journal of Rheumatology|November 3, 2018
Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparisonWalter P Maksymowych, Vibeke Strand, Peter Nash, et al.
European Journal of Neurology|June 10, 2026
Defining Activity-Based Subgroups in Multiple Sclerosis: A Review and Framework ProposalCatalina Lopez Manzano, Claire M Rice, Emma Tallantyre, et al.
Pageof 7